Literature DB >> 23773772

Definitions of terms, processes and a minimum dataset for transperineal prostate biopsies: a standardization approach of the Ginsburg Study Group for Enhanced Prostate Diagnostics.

Timur H Kuru1, Karan Wadhwa, Richard Tsung Meng Chang, Lina Maria Carmona Echeverria, Matthias Roethke, Alexander Polson, Giles Rottenberg, Brendan Koo, Edward M Lawrence, Jonas Seidenader, Vincent Gnanapragasam, Richard Axell, Wilfried Roth, Anne Warren, Andrew Doble, Gordon Muir, Rick Popert, Heinz-Peter Schlemmer, Boris A Hadaschik, Christof Kastner.   

Abstract

OBJECTIVES: To define terms and processes and agree on a minimum dataset in relation to transperineal prostate biopsy procedures and enhanced prostate diagnostics. To identify the need for further evaluation and establish a collaborative research practice. PATIENTS AND METHODS: A 19-member multidisciplinary panel rated 66 items for their appropriateness and their definition to be incorporated into the international databank using the Research and Development/University of California Los Angeles Appropriateness Method. The item list was developed from interviews conducted with healthcare professionals from urology, radiology, pathology and engineering.
RESULTS: The panel agreed on 56 items that were appropriate to be incorporated into a prospective database. In total, 10 items were uncertain and were omitted. These items were within the categories: definitions (n = 2), imaging (n = 1), surgical protocols (n = 2) and histology (n = 5).
CONCLUSIONS: The components of a minimum dataset for transperineal prostate biopsy have been defined. This provides an opportunity for multicentre collaborative data analysis and technique development. The findings of the present study will facilitate prospective studies into the application and outcome of transperineal prostate biopsies.
© 2013 BJU International.

Entities:  

Keywords:  biopsy; consensus; dataset; standardization; template; transperineal

Mesh:

Year:  2013        PMID: 23773772     DOI: 10.1111/bju.12132

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  42 in total

1.  [Multiparametric MRI and MRI-TRUS fusion biopsy in patients with prior negative prostate biopsy].

Authors:  C Kesch; J P Radtke; F Distler; S Boxler; T Klein; C Hüttenbrink; K Hees; W Roth; M Roethke; H P Schlemmer; M Hohenfellner; B A Hadaschik
Journal:  Urologe A       Date:  2016-08       Impact factor: 0.639

Review 2.  PI-RADS Steering Committee: The PI-RADS Multiparametric MRI and MRI-directed Biopsy Pathway.

Authors:  Anwar R Padhani; Jelle Barentsz; Geert Villeirs; Andrew B Rosenkrantz; Daniel J Margolis; Baris Turkbey; Harriet C Thoeny; François Cornud; Masoom A Haider; Katarzyna J Macura; Clare M Tempany; Sadhna Verma; Jeffrey C Weinreb
Journal:  Radiology       Date:  2019-06-11       Impact factor: 11.105

3.  Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer.

Authors:  Frank-Jan H Drost; Daniël F Osses; Daan Nieboer; Ewout W Steyerberg; Chris H Bangma; Monique J Roobol; Ivo G Schoots
Journal:  Cochrane Database Syst Rev       Date:  2019-04-25

4.  Risk stratification system for biparametric prostate magnetic resonance imaging.

Authors:  Eugenio Martorana; Pietro Scialpi; Riccardo Grisanti; Michele Scialpi
Journal:  Transl Androl Urol       Date:  2019-12

5.  Investigating the ability of multiparametric MRI to exclude significant prostate cancer prior to transperineal biopsy.

Authors:  Eva M Serrao; Tristan Barrett; Karan Wadhwa; Deepak Parashar; Julia Frey; Brendan C Koo; Anne Y Warren; Andrew Doble; Christof Kastner; Ferdia A Gallagher
Journal:  Can Urol Assoc J       Date:  2015-12-14       Impact factor: 1.862

6.  Prostate Imaging-Reporting and Data System Steering Committee: PI-RADS v2 Status Update and Future Directions.

Authors:  Anwar R Padhani; Jeffrey Weinreb; Andrew B Rosenkrantz; Geert Villeirs; Baris Turkbey; Jelle Barentsz
Journal:  Eur Urol       Date:  2018-06-13       Impact factor: 20.096

7.  Prostate cancer: performance characteristics of combined T₂W and DW-MRI scoring in the setting of template transperineal re-biopsy using MR-TRUS fusion.

Authors:  Edward M Lawrence; Sarah Y W Tang; Tristan Barrett; Brendan Koo; Debra A Goldman; Anne Y Warren; Richard G Axell; Andrew Doble; Ferdia A Gallagher; Vincent J Gnanapragasam; Christof Kastner; Evis Sala
Journal:  Eur Radiol       Date:  2014-04-18       Impact factor: 5.315

Review 8.  Transperineal prostate biopsy: The modern gold standard to prostate cancer diagnosis.

Authors:  Gernot Ortner; Eirini Tzanaki; Bhavan Prasad Rai; Udo Nagele; Theodoros Tokas
Journal:  Turk J Urol       Date:  2020-10-09

9.  Evolution of repeat prostate biopsy strategies incorporating transperineal and MRI-TRUS fusion techniques.

Authors:  Timur H Kuru; Kasra Saeb-Parsy; Andrea Cantiani; Julia Frey; Riccardo Lombardo; Eva Serrao; Gabriele Gaziev; Brendan Koo; Matthias Roethke; Vincent Gnanapragasam; Anne Warren; Andrew Doble; Boris Hadaschik; Christof Kastner
Journal:  World J Urol       Date:  2014-06-11       Impact factor: 4.226

10.  [Value of MRI/ultrasound fusion in primary biopsy for the diagnosis of prostate cancer].

Authors:  F Distler; J P Radtke; C Kesch; M Roethke; H-P Schlemmer; W Roth; M Hohenfellner; B Hadaschik
Journal:  Urologe A       Date:  2016-02       Impact factor: 0.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.